Fairmount Funds Management LLC, a Delaware limited liability company (hereinafter
“Fairmount,” “we”, “us”, “our” or the “Firm”), was founded by Peter Harwin and Tomas
Kiselak, the principal owners of the Firm (the “Managing Members”) in August 2016. The
Managing Members are responsible for the Firm’s daily management and portfolio selection.
Fairmount Healthcare Fund II GP LLC and Fairmount Healthcare Co-Invest II GP LLC both
Delaware limited liability companies (the “General Partners”), are affiliated with the Firm and
owned by the Managing Members.
Fairmount provides discretionary investment management services to qualified investors
through its privately placed pooled investment vehicles (the “Funds”):
(i) Fairmount Healthcare Fund II LP (“Fairmount Healthcare Fund II”) and
Fairmount Healthcare Feeder Fund II LP (“Offshore Fund II,” and together
with Fairmount Healthcare Fund II, the “Partnerships”);
(ii) one Special Purpose Vehicle (the “SPV”); and
(iii) Fairmount Healthcare Co-Invest II LP (“Co-invest II”).
Offshore Fund II invests all its assets in Fairmount Healthcare Fund II. Offshore Fund II’s
shareholders, Fairmount Healthcare Fund II and Co-invest II’s limited partners, and the
members of the
SPV are hereafter collectively referred to as the “Investors” where
appropriate. We do not tailor our advisory services to the individual needs of any Investor.
Fairmount manages investments primarily focused on healthcare and life science companies,
including companies developing drugs, devices, diagnostics, services, and/or healthcare IT.
Investments are generally comprised of common stock, preferred shares, warrants, options,
baskets of securities, exchange-traded funds, restricted shares, contingent value rights, and
investments in privately held companies. We focus on small and midsize market
capitalization companies and may invest long and/or short and may choose to hedge some
or all of our positions.
As of December 31, 2023, the Firm managed approximately $2,277,000,000 in client assets,
all of which were managed on a discretionary basis.
Information about the Funds presented in this Brochure is indicative of Fund terms and
practices. Interests in any Fund are offered to eligible investors only through their respective
confidential offering memoranda and other offering and governing documents, which should
be read in their entirety prior to investment. This Brochure is not an offer of interests in any
Fund.